Article Details
Retrieved on: 2024-10-04 18:05:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“The identification of this residual risk subtype opens new avenues for tailored treatments,” Frank Vicini, MD, of Michigan Healthcare Professionals ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here